DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pqjm3l/the_overview_of) has announced the addition of the "Overview of Japanese CRO Market 2014 Featuring Cimic, EPS, Mediscience Planning, Parexel & Quintiles " report to their offering.
Japanese CROs get local projects, and global CROs take global studies. Japanese CROs leverage their low cost and ability to interact with clients in Japanese, to get domestic studies. On the other hand, global CROs, takes advantage of their capability in international studies and global reach.
In this situation, large Japanese CROs have been trying to expand the operation in Asia, to get multinational studies. Also, some CROs such as CMIC are moving into horizontal business expansion; CSO, CMO etc., positioning themselves as one-stop service provider for entire pharmaceutical business.
Large foreign-owned CROs are strengthening regional capability, investing facilities and resources in functional services such as central laboratories, imaging, clinical supply and so on, to take domestic projects away from local CROs.
Demand for outsourcing clinical development works has remained strong. Therefore, Japanese CRO market will likely continue to grow for a while. More concentration into the top 4 companies is also expected in the near future. The environment surrounding small- and mid-sized CROs will become difficult more and more over the time. The key to success for them to survive this tough market would be securing quality operational staff that can satisfy clients' needs.
Key Topics Covered:
1. Summary
2. Definition of CRO market
3. Market size
4. Rational necessity for pharma to use CRO
5. Industry Association
6. Major CRO companies
7. Market trend
8. Future outlook
Companies Mentioned
- Cimic
- EPS
- Mediscience Planning
- Parexel
- Quintiles
For more information visit http://www.researchandmarkets.com/research/pqjm3l/the_overview_of
